The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain
tumors and other central nervous system (CNS) diseases. The Eleventh Annual Blood-Brain …

Advances in nanotechnology have the potential to dramatically enhance the detection of
neurologic diseases with targeted contrast agents and to facilitate the delivery of focused …

Advancements in imaging of the central nervous system have paralleled and propelled
neurosurgical practice. These technologic innovations have expanded our understanding of …

Nanotechnology involves the design, synthesis, and characterization of materials and
devices that have a functional organization in at least one dimension on the nanometer (ie …

Targeting across the blood–brain barrier (BBB) for treatment of central nervous system
(CNS) diseases represents the most challenging aspect of, as well as one of the largest …

Applications of nanotechnology to medicine are leading to novel means of imaging living
systems and of delivering therapy. Much nanotechnology research is focused on methods …

Rapid advances in the field of nanotechnology promise revolutionary improvements in the
diagnosis and therapy of neuroinflammatory disorders. An array of iron oxide nano-and …

The use of nanoparticles in diagnostic imaging is rapidly gaining utility and acceptance. A
handful of iron oxide nanoparticle compounds have already been approved by the US Food …

The incidence of neurological diseases of unknown etiology is increasing, including well-
studied diseases such as Alzhiemer's, Parkinson's, and multiple sclerosis. The blood-brain …

Nanobiotechnologies that are currently under investigation in the life sciences,
pharmaceuticals and diagnostics will soon find applications in the practice of medicine [1] …